Imago BioSciences (Imago BioSciences) Book Value per Share : $5.11 (As of Sep. 2022)

View and export this data going back to 2021. Start your Free Trial

What is Imago BioSciences Book Value per Share?

Imago BioSciences's book value per share for the quarter that ended in Sep. 2022 was $5.11.

During the past 12 months, Imago BioSciences's average Book Value Per Share Growth Rate was -25.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

Imago BioSciences's current price is $36.01. Its book value per share for the quarter that ended in Sep. 2022 was $5.11. Hence, today's PB Ratio of Imago BioSciences is 7.05.

During the past 3 years, the highest P/B Ratio of Imago BioSciences was 7.05. The lowest was 0.00. And the median was 0.00.

Imago BioSciences Book Value per Share Historical Data

The historical data trend for Imago BioSciences's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Imago BioSciences Book Value per Share Chart

Imago BioSciences Annual Data

Trend

Dec19

Dec20

Dec21

Book Value per Share

-3.84

-3.06

6.40

Imago BioSciences Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Book Value per Share	Get a 7-Day Free Trial							6.83	6.40	5.91	5.55	5.11

Competitive Comparison of Imago BioSciences's Book Value per Share

For the Biotechnology subindustry, Imago BioSciences's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Imago BioSciences's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Imago BioSciences's PB Ratio distribution charts can be found below:

* The bar in red indicates where Imago BioSciences's PB Ratio falls into.

Imago BioSciences Book Value per Share Calculation

Imago BioSciences's Book Value Per Share for the fiscal year that ended in Dec. 2021 is calculated as:

Book Value Per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(214.69	-	0.00)	/	33.53
	=	6.40

Imago BioSciences's Book Value Per Share for the quarter that ended in Sep. 2022 is calculated as:

Book Value Per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(172.62	-	0.00)	/	33.82
	=	5.10

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.

Imago BioSciences (NAS:IMGO) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.

Imago BioSciences Book Value per Share Related Terms

Thank you for viewing the detailed overview of Imago BioSciences's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Imago BioSciences (Imago BioSciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Imago BioSciences Inc (NAS:IMGO) » Definitions » Book Value per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

329 Oyster Point Boulevard, 3rd Floor, South San Francisco, CA, USA, 94080

Website

https://www.imagobio.com

Imago BioSciences Inc is a clinical-stage biopharmaceutical company discovering and developing novel small molecule product candidates that target lysine-specific demethylase 1 (LSD1), an enzyme that plays a central role in the production of blood cells in the bone marrow. It is focused on improving the quality and length of life for patients with cancer and bone marrow diseases. Bomedemstat, an orally available, small molecule inhibitor of LSD1, is the product candidate discovered by Imago for the treatment of certain myeloproliferative neoplasms (MPNs), a family of related, chronic cancers of the bone marrow. Imago is evaluating Bomedemstat as a potentially disease-modifying therapy in two Phase 2 clinical trials for the treatment of essential thrombocythemia (ET) and myelofibrosis (MF).

Executives

Laura G. Eichorn	officer: Chief Operating Officer	IMAGO BIOSCIENCES, INC., 329 OYSTER POINT BLVD. 3RD FL, SOUTH SAN FRANCISCO CA 94080
Michael Arenberg	officer: See Remarks	10260 BUBB ROAD, CUPERTINO CA 95014
Hugh Jr Rienhoff	director, officer: Chief Executive Officer	IMAGO BIOSCIENCES, INC., 329 OYSTER POINT BLVD. 3RD FL, SOUTH SAN FRANCISCO CA 94080
Amy E. Tapper	officer: See Remarks	IMAGO BIOSCIENCES, INC., 329 OYSTER POINT BLVD. 3RD FL, SOUTH SAN FRANCISCO CA 94080
Jennifer Peppe	officer: See Remarks	IMAGO BIOSCIENCES, INC., 329 OYSTER POINT BLVD. 3RD FL, SOUTH SAN FRANCISCO CA 94080
Hsiangyi Chiang	officer: Senior Vice President Finance	C/O IMAGO BIOSCIENCES, INC., 329 OYSTER POINT BLVD. 3RD FLOOR, SOUTH SAN FRANCISCO CA 94080
Blackstone Inc.	10 percent owner	345 PARK AVENUE, NEW YORK NY 10154
Blackstone Clarus Iii L.l.c.	10 percent owner	C/O THE BLACKSTONE GROUP L.P., 345 PARK AVENUE, NEW YORK NY 10154
Clarus Ventures Iii Gp, L.p.	10 percent owner	C/O CLARUS VENTURES, 101 MAIN STREET, SUITE 1210, CAMBRIDGE MA 02142
Clarus Lifesciences Iii, L.p.	10 percent owner	101 MAIN STREET, SUITE 1210, CAMBRIDGE MA 02142
Stephen A Schwarzman	10 percent owner	C/O BLACKSTONE INC., 345 PARK AVE, NEW YORK NY 10154
Blackstone Group Management L.l.c.	10 percent owner	C/O BLACKSTONE INC., 345 PARK AVENUE, NEW YORK NY 10154
Blackstone Holdings I/ii Gp L.l.c.	10 percent owner	C/O BLACKSTONE INC., 345 PARK AVENUE, NEW YORK NY 10154
Blackstone Holdings Ii L.p.	10 percent owner	C/O BLACKSTONE INC., 345 PARK AVENUE, NEW YORK NY 10154
Laurie Keating	director	300 THIRD STREET, CAMBRIDGE MA 02142